These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 6294181
1. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. Edson CM, Cohen LK, Henle W, Strominger JL. J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181 [Abstract] [Full Text] [Related]
3. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M, Rezbová M, Svecová M, Hrbácková H, Novotná M, Ochotná J, Roubalová K. Klin Mikrobiol Infekc Lek; 2004 Aug 15; 10(4):186-90. PubMed ID: 15328576 [Abstract] [Full Text] [Related]
4. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series. Fark AR. J Fam Pract; 1991 Feb 15; 32(2):202, 205-6, 209. PubMed ID: 1846641 [Abstract] [Full Text] [Related]
5. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Jones JF, Williams M, Schooley RT, Robinson C, Glaser R. Arch Intern Med; 1988 Sep 15; 148(9):1957-60. PubMed ID: 2843138 [Abstract] [Full Text] [Related]
6. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Touge C, Agawa H, Sairenji T, Inoue Y. Arch Virol; 2006 May 15; 151(5):895-903. PubMed ID: 16362642 [Abstract] [Full Text] [Related]
7. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G. Cancer Res; 1984 Mar 15; 44(3):1288-300. PubMed ID: 6318984 [Abstract] [Full Text] [Related]
8. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen. Dölken G, Boldt C, Lange W, Weitzmann U, Löhr GW, Rosén A. Cancer Detect Prev; 1983 Mar 15; 6(1-2):287-92. PubMed ID: 6309387 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells. Daibata M, Sairenji T. Virology; 1993 Oct 15; 196(2):900-4. PubMed ID: 8396819 [Abstract] [Full Text] [Related]
10. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282 [Abstract] [Full Text] [Related]
11. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. Jenson HB, Montalvo EA, McClain KL, Ench Y, Heard P, Christy BA, Dewalt-Hagan PJ, Moyer MP. J Med Virol; 1999 Jan 15; 57(1):36-46. PubMed ID: 9890420 [Abstract] [Full Text] [Related]
12. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1]. Kwon KW. Hokkaido Igaku Zasshi; 1995 Mar 15; 70(2):315-28. PubMed ID: 7774883 [Abstract] [Full Text] [Related]
13. [Malignant lymphoma which contained EBV DNA and lacked EBNA2 antibody]. Shimakage M, Hirai K, Ikegami N, Matsubuchi T, Kawagoe H. Rinsho Ketsueki; 1989 Jul 15; 30(7):1091-2. PubMed ID: 2554014 [Abstract] [Full Text] [Related]
14. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT, Fernandes BJ, Mock D. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 15; 92(2):184-93. PubMed ID: 11505266 [Abstract] [Full Text] [Related]
15. Antibodies to Epstein-Barr virus-induced early antigens in blood donors. Wohlrabe P, Färber I, Wutzler P, Uhlig R. Acta Virol; 1989 Aug 15; 33(4):344-8. PubMed ID: 2574941 [Abstract] [Full Text] [Related]
16. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J, Pai S, Cotter M, Robertson ES. Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. Blaschke S, Schwarz G, Moneke D, Binder L, Müller G, Reuss-Borst M. J Rheumatol; 2000 Apr 15; 27(4):866-73. PubMed ID: 10782808 [Abstract] [Full Text] [Related]
18. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV. Ishida T, Yamamoto K. J Med Primatol; 1987 Apr 15; 16(6):359-71. PubMed ID: 2828628 [Abstract] [Full Text] [Related]
19. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. Takashima K, Ohashi M, Kitamura Y, Ando K, Nagashima K, Sugihara H, Okuno K, Sairenji T, Hayashi K. J Med Virol; 2008 Mar 15; 80(3):455-66. PubMed ID: 18205213 [Abstract] [Full Text] [Related]
20. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G, Dewey F, Klein G, Henle G, Henle W. J Natl Cancer Inst; 1970 Nov 15; 45(5):989-95. PubMed ID: 18605425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]